274 related articles for article (PubMed ID: 34599025)
1. Nivolumab-associated DRESS in a genetic susceptible individual.
Ai L; Gao J; Zhao S; Li Q; Cui YH; Liu Q; Wu D; Wang Y; Jin X; Ji Y; Li J; Yu Y; Liu T
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599025
[TBL] [Abstract][Full Text] [Related]
2. Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration.
Maximova N; Maestro A; Zanon D; Marcuzzi A
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32066648
[TBL] [Abstract][Full Text] [Related]
3. Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases.
Ingen-Housz-Oro S; Milpied B; Bensaid B; Elshot Y; Brüggen MC; Starace M; Kaffenberger BH; Carrera C; Pham-Ledard A; Freites-Martinez A; Sanchez-Pena P; Lebrun-Vignes B; French LE; Sibaud V
Melanoma Res; 2023 Apr; 33(2):155-158. PubMed ID: 36749114
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report.
Tominaga K; Takeuchi K; Takakuma S; Sakamoto E; Hatanaka S; Kajimoto Y; Toda E; Terasaki Y; Kunugi S; Terasaki M; Shimizu A
BMC Nephrol; 2023 Mar; 24(1):48. PubMed ID: 36894873
[TBL] [Abstract][Full Text] [Related]
5. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients.
Liu Q; Zhao S; Chen W
J Clin Pharm Ther; 2022 Sep; 47(9):1368-1378. PubMed ID: 35971667
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS).
Chou HY; Chen CB; Cheng CY; Chen YA; Ng CY; Kuo KL; Chen WL; Chen CH
J Clin Pharm Ther; 2015 Dec; 40(6):689-92. PubMed ID: 26365588
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
[TBL] [Abstract][Full Text] [Related]
9. Sulthiame-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Fong CY; Hashim N; Gan CS; Chow TK; Tay CG
Eur J Paediatr Neurol; 2016 Nov; 20(6):957-961. PubMed ID: 27524391
[TBL] [Abstract][Full Text] [Related]
10. Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
Thomas M; Hopkins C; Duffy E; Lee D; Loulergue P; Ripamonti D; Ostrov DA; Phillips E
Clin Infect Dis; 2017 May; 64(9):1198-1203. PubMed ID: 28369189
[TBL] [Abstract][Full Text] [Related]
11. DRESS Syndrome: Renal Involvement in Two Cases - A Comprehensive Analysis and Literature Review of Improved Diagnosis and Treatment.
Mąsior MN; Rostkowska OM; Furmańczyk-Zawiska A; Wieczorek-Godlewska R; Wyzgał M; Durlik M
Am J Case Rep; 2024 Jan; 25():e942315. PubMed ID: 38204155
[TBL] [Abstract][Full Text] [Related]
12. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.
Konvinse KC; Trubiano JA; Pavlos R; James I; Shaffer CM; Bejan CA; Schutte RJ; Ostrov DA; Pilkinton MA; Rosenbach M; Zwerner JP; Williams KB; Bourke J; Martinez P; Rwandamuriye F; Chopra A; Watson M; Redwood AJ; White KD; Mallal SA; Phillips EJ
J Allergy Clin Immunol; 2019 Jul; 144(1):183-192. PubMed ID: 30776417
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Hagiya H; Iwamuro M; Tanaka T; Hasegawa K; Hanayama Y; Kimura M; Otsuka F
Intern Med; 2016; 55(13):1769-74. PubMed ID: 27374681
[TBL] [Abstract][Full Text] [Related]
14. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
[TBL] [Abstract][Full Text] [Related]
15. DRESS syndrome: quetiapine associated case report and literature review.
Mallaro HL; Rosenthal LJ
Int Clin Psychopharmacol; 2023 Sep; 38(5):356-360. PubMed ID: 37159165
[TBL] [Abstract][Full Text] [Related]
16. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.
Ganeshanandan L; Lucas M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498771
[TBL] [Abstract][Full Text] [Related]
17. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
18. The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.
Chen WT; Wang CW; Lu CW; Chen CB; Lee HE; Hung SI; Choon SE; Yang CH; Liu MT; Chen TJ; Fan WL; Su SC; Lin YY; Chang YC; Chung WH;
J Invest Dermatol; 2018 Jul; 138(7):1546-1554. PubMed ID: 29458119
[TBL] [Abstract][Full Text] [Related]
19. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cardones AR
Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
